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?INTRODUCTION
Carcinoma of the cervix is one of the commonest malignancies among women
in India. About 1, 00,000 women are diagnosed with cervical cancer each year.
[1] An accurate pre-treatment staging of cervical cancer is critical, as it
determines the therapeutic approach. The International Federation of
Gynecology and Obstetrics (FIGO) in collaboration with the World Health
Organization (WHO) and the International Union against Cancer (IUCC)
established the most commonly used staging system for cervical cancer [2].
FIGO guidelines allow the following examinations for establishing the stage of
disease, but it is not mandatory to perform all of these tests on every patient [3].
Palpation and inspection of the primary tumor, palpation of groin and
supraclavicular lymph nodes , colposcopy , endocervical curettage, conization,
hysteroscopy, cystoscopy, proctoscopy, intravenous pyelogram (IVP) and
radiographic examination of the lungs and skeleton. Women in resource-poor
countries, which have a high prevalence of cervical cancer, generally do not
have access to advanced imaging modalities and specialized surgical care, and
the majority of patients are treated with primary radiation.
After histologic confirmation of invasive cervical cancer, the extent of disease
needs to be determined. Two staging systems are available, both of which use
clinical criteria to assign disease stage. As with all gynecologic cancers, tumor
?stage is determined at the time of primary diagnosis and is not altered, even if
disease recurs.
Cystoscopy is necessary to establish the diagnosis of bladder invasion by
cervical carcinoma. However, it is an invasive investigation and may cause
patient discomfort. Different studies [5,6,7] have assessed the usefulness of
cystoscopy in comparison to to imaging modalities (ultrasonogram and CT
scan). They have concluded that cystoscopy is required in select group of
patients only.
Transabdominal sonography is a first-line imaging technique for evaluation of
the upper and lower abdomen because it s almost universally available, is
noninvasive, lacks ionizing radiation, and is well accepted by patients. Studies
focusing on sonography as a diagnostic tool for focal bladder wall abnormalities
(FBWAs) are scant. Most of these studies were retrospective, sometimes
conducted in small cohorts of patients, and all were carried out with old
sonography equipment[1].
With the invention of imaging modalities with advanced technology, the yield
has considerably improved. In few studies available, comparison between CT
?scan and cystoscopy, as well as transvaginal ultrasonogram and have been done.
But studies comparing transabdominal ultrasound and cystoscopy are limited.
In this context, our attempt was to prospectively assess the usefulness of
transabdominal ultrasonogram in the staging of cervical carcinoma to detect
bladder mucosal infiltration and to compare with cystoscopy. This will help to
select the patients for cystoscopy so that a routine invasive procedure can be
avoided.
?AIM
                  The aim of this study was to assess the usefulness of cystoscopy in
staging of carcinoma cervix and to determine the potential of transabdominal
ultrasonography to demonstrate the presence or absence of bladder infiltration
in patients with cervical carcinoma.
??
REVIEW OF LITERATURE
The pretreatment assessment of cancer extension is extremely important for
prognosis estimation and treatment planning. Additionally, a well-defined
initial assessment enables the comparison of cancer treatment results among
institutions or different treatment methods. The International Federation of
Gynecology and Obstetrics (FIGO) provides a global staging system for
gynecologic cancers . Most clinicians use this staging system in the treatment of
uterine cervical cancer. The system describes the rules for stage classification in
detail, and the permitted diagnostic procedures are clearly stated. However,
some of the procedures included, such as intravenous urography, and skeletal
X-rays, could be considered outdated. Although tumor diameter and pelvic
nodal status are not accounted for in the FIGO staging system, they are
estimated to be the important prognostic factors for cervical cancer. In several
studies, tumor diameter as assessed by MRI was a significant prognostic
indicator for patients with cervical cancer. Evaluation of pelvic or para-aortic
lymph node status with optional imaging studies, such as CT, MRI, and
lymphangiograpy, may also be useful for predicting prognosis (6).
??
3.1 Epidemiology
Carcinoma of the cervix is the 6th most common malignant neoplasm in  human
after carcinoma breast, lung, colorectal, endometrial and ovary. It is the second
leading cause of female cancer deaths in the underdeveloped countries
[9].iCarcinoma cervix is more common in women who had first intercourse at
an early age, have a history of promiscuity and large number of pregnancies
[10,11,12]
The peak incidence for invasive cancer is between 45 and 50 years of age,
although there has been a rise in the 25–34-year age range. The peak incidence
of CIN is 25–40 years of age. Currently, the mortality rate from cervical cancer
is falling by almost 7% annually, which has been attributed mainly to the
success of the cervical screening programme. Squamous cell carcinoma
accounts for the majority of cases of invasive cervical cancer although, since
1998, there has been a significant rise in the proportion of cases of
adenocarcinoma and adenosquamous carcinoma.
The most common type of invasive cancer of the cervix is squamous cell
carcinoma, with  subtypes, papillary (squamotransitional) subtype, the
verrucous subtype and the lymphoepithelioma-like subtype [13].
??
Various aetiological factors have been associated with cervical cancer. Among
these are human papillomaviruses (HPVs), smoking, sexual behaviour,
immunosuppression (such as women who are HIV-positive and women
undergoing renal transplant who are taking immunosuppressants) and combined
oral contraceptive pills. There is now overwhelming evidence that HPVs are the
main cause of both preinvasive and invasive squamous cell carcinoma of the
cervix in nearly 100% of cases. s
3.2 Clinical presentation
Early invasive carcinoma of the cervix can be detected before it becomes
symptomatic by cytological smears. Serosanguinous or yellowish, foul-smelling
vaginal discharge may be noted in patients with invasive carcinoma,
particularly with more advanced necrotic lesions. If chronic bleeding occurs,
the patient may complain of fatigue or other symptoms related to anemia.
Pain, usually in the pelvis or hypogastrium, may be noted and could be caused
by tumor necrosis or associated pelvic inflammatory disease. Some patients
may complain of pain in the lumbosacral area, and in these cases the possibility
of paraaortic lymph node involvement with extension in to the lumbosacral
roots or hydronephrosis should be considered. Occasionally epigastric pain may
be caused by metastasis to high para-aortic lymph nodes. Urinary and rectal
??
symptoms (hematuria, rectal bleeding) may appear in advanced stages as a
consequence of invasion of the bladder or rectum by the neoplasm [14].
3.3 Staging
Meticulous staging of cervical cancer is important in determining the most
appropriate form of treatment, as well as being a prognostic indicator. It is also
valuable in comparing therapy results.[2]. Staging is based on clinical
evaluation.Apart from stages Ia1 and Ia2 (where histological diagnosis is
usually made from a cone or loop cervical biopsy, depending on the depth and
horizontal extent of the disease), staging of cervical cancer is clinical,
preferably by examination under anaesthesia by an experienced clinician.
Thereafter, the stage should not be altered because of subsequent findings. The
International Federation of Gynecology and obstetrics (FIGO) recommends that
if there is any doubt as to which stage a particular cancer should be allocated,
the earlier stage is mandatory[2].
The prognosis of cervical carcinoma is primarily determined by the stage of
disease, the volume of the primary tumor, and the histologic grade. The current
staging system for cervical cancer is based on the FIGO classification. It defines
the clinical staging system for cervical carcinoma based on clinical assessment
including physical examination under anesthesia, colposcopy, endocervical
??
curettage, hysteroscopy, cystoscopy, proctoscopy, IVU, Barium enema, and X-
rays of lungs and skeleton. Errors in clinical FIGO staging have been reported.
When compared with surgical findings, FIGO staging errors are 28% in stage Ib
disease and 50%-64% in stage IIa-IIb disease. Clinical evaluation
underestimates the surgical stage in 15%-36% of patients. In clinically staged Ib
disease, underestimation of tumor extent occurs in 21% and overestimation in
6% of patients. Inaccuracy in clinical staging is predominantly due to
difficulties in evaluating parametrial and pelvic sidewall invasion, bladder or
rectal wall invasion, metastatic spread, and in evaluating primary endocervical
(endophytic) tumors. Aside from the inaccuracies 8 of 14 of clinical staging,
evaluation of lymph node metastasis, which is an important prognostic factor
and a determinant in treatment planning, is not included in the clinical staging
system. In surgically treated stages Ib and IIa cervical cancer, survival rates
decline from 85%-90% to 50%-55%, respectively, in the presence of metastatic
lymph nodes. In spite of these limitations of clinical FIGO staging, modern
cross-sectional imaging modalities such as US, CT, and MRI have not been
incorporated into clinical staging. Among the most common arguments against
the use of CT or MRI as staging tools are their high cost and unavailability
universally.
Cystoscopy is performed to exclude bladder involvement and a rectovaginal
examination should be performed to determine the tumour bulk and the
??
presence of any parametrial or pelvic sidewall extension.[2] In women selected
for surgery, adjuvant radiotherapy increases the risk of  complications so should
be avoided if possible. Accurate staging should, therefore, be obtained before
commencing definitive therapy. Surgery or radiotherapy may be used as the
primary treatment or in combination, although definitive surgery is usually
limited to women with early-stage cervical cancer in whom radiotherapy may
be avoided.[2]
Bladder involvement caused by local infiltration by cervical carcinoma has
important therapeutic and prognostic implications. Evaluation of the bladder for
infiltration is therefore an integral part of the clinical staging procedure.
Cystoscopy, supported by cystoscopically directed biopsy is the only
investigation accepted by FIGO as the gold standard for the diagnosis of
bladder infiltration. [5]
3.3.1 FIGO staging of cervical cancer
Staging of Carcinoma of the uterine cervix is staged and managed by means of
the International Federation of Gynecology and Obstetrics (FIGO) staging
system. The FIGO staging system is determined preoperatively mainly by the
??
clinical assessment. This was seen to be quit sufficient for early stage disease,
but it has inherent inaccuracies in advanced stage disease. It does not take into
account the nodal involvement. Though not routinely used in the developing
countries, CT and MR imaging are widely used elsewhere to evaluate tumour
size and extent, and nodal involvement. In this it was found that MR imaging is
excellent for depicting invasive cervical carcinoma with objective measurement
of tumour volume. It rules out conclusively parametrial invasion and stage IVA
disease [15].
Invasive cervical cancer may spread to the lower urinary tract by direct
invasion. Examination of the ureters and bladder is very important in evaluating
the extent and spread  in cervical cancer. The two methods most commonly
used in the evaluation of the urinary tract in cervical cancer patients are
excretory urography and cystoscopy.
In the FIGO staging of cervical cancer, excretory urography has been
considered an integral part of the initial evaluation because the presence of
hydronephrosis or nonfunctioning kidney resulting from ureteral obstruction
advances the staging to 3B and is of prognostic importance. Several studies
have showed that the accuracies of excretory urography, CT and MRI in the
??
detection of urinary tract obstruction are similar. Therefore, it is not necessary
to perform excretory uogram when CT or MRI are done.
The use of FIGO permitted examinations (e.g. intravenous urography,
cystoscopy, and proctoscopy) is gradually decreasing in the USA [32,33]. In a
2000 –02 US study on the pretreatment evaluation of patients with stage IIB or
less disease, the rates for performing intravenous urography, cystoscopy, and
proctoscopy were 1, 16, and 17%, respectively [33]. In contrast, the present
study demonstrated that these exams were performed frequently even for early
stage cases in Japan. Schmitz et al. [34]  proposed that since the likelihood of
upstaging using these examinations was very low in clinical stage IB patients,
these exams could be omitted in those with stage IB disease. Now, the National
Comprehensive Cancer Network (NCCN) guideline states that cystoscopy
and proctoscopy are optional exams for the pretreatment assessment of cervical
cancer patients with a disease stage of IB2 or higher.
Classification Criteria (FIGO/UICC 1997)
TNM FIGO
TX Primary tumour cannot be assessed
??
T0 No evidence of primary tumour
TIS 0 Carcinoma in situ (preinvasive
carcinoma)
T1 I Cervical carcinoma confined to uterus
(extension to corpus should be
disregarded)
T1a IA Invasive cancer identified only
microscopically. All gross lesions even
with superficial invasion are stage
T1b/IB cancers.
T1a1 IA1 Stromal invasion no greater than 3.0 mm
in depth and no wider than 7.0 mm
T1a2 IA2 Measured invasion of stroma greater
than 3.0 mm and no greater than 5.0 mm
with horizontal spread 7.0 mm or less
T1b IB Clinical lesions confined to the cervix or
microscopic lesion greater than
T1a2/IA2
T1b1 IB1 Clinical lesions not greater than 4.0 cm
??
in size
T1b2 IB2 Clinical lesions greater than 4.0 cm in
size
T2 II Tumour invades beyond uterus but not to pelvic
wall or to lower third of the vagina
T2a IIA Without parametrial invasion
T2b IIB With parametrial invasion
T3 III Tumour extends to pelvic wall and/or
involves lower third of vagina and/or
causes hydronephrosis or non-
functioning kidney
T3a IIIA Tumour involves lower third of vagina,
no extension to pelvic wall
T3b IIIB Tumour extends to pelvic wall and/or
causes hydronephrosis or non-
functioning kidney
T4 IVA Tumour invades mucosa of bladder or
rectum and/or extends beyond true pelvis
??
Fig 1 : Staging of Carcinoma  Cervix
??
The following is the recommended investigations for the work up of
carcinoma of cervix
Diagnostic work-up for carcinoma of the uterine cervix[16]
General *History
*Physical examination, including bimanual pelvic and
rectal examinations
Diagnostic procedures *Cytological smears(Papanicolaou) if not bleeding
*Colposcopy
*Conization (subclinical tumor)
*Punch biopsies (edge of gross tumor, four  quadrants)
*Dilatation and curettage
*Cystoscopy, rectosigmoidoscopy(stages IIB, III, and IVA
Radiographic Studies Standard
  *Chest radiography
  *Intravenous pyelography
  *Barium enema (stages III and IVA and earlier
stages if there are symptoms referable to colon or rectum)
Complementary
   *Lymphangiography
   *Computed tomography or magnetic resonance imaging
   *Positron emission tomography scan(optional)
??
Radiographic Studies Standard
  *Chest radiography
  *Intravenous pyelography
  *Barium enema (stages III and IVA and earlier
stages if there are symptoms referable to colon or rectum)
Complementary
   *Lymphangiography
   *Computed tomography or magnetic resonance imaging
   *Positron emission tomography scan(optional)
Laboratory studies    *Complete blood count
   *Blood chemistry
   *Urinalysis
3.3.2 Current role of Imaging
The most important issue in staging cervical cancer is to distinguish early
disease (stage 1A and 1B) that can be treated with surgery from advanced
disease that must be treated with radiation alone or combined with
chemotherapy. Imaging modalities must be directed to solve this clinically
important question. Conventional radiological studies such as excretory
urography, barium enema and lymphangiography are less commonly used
??
today. However, there has been an increase in the use of cross-sectional
imaging like CT and MRI [17].
Thus, the specific questions that can be answered by imaging for the staging
of invasive cervical cancer are a) extension of tumour into the parametrium,
pelvic sidewall, bladder and rectum b) presence of hydronephrosis secondary
to ureteric obstruction c) detection of lymph nodes and d) detection of local
recurrence and distal metastatsis [18].
Transabdominal sonography is a first-line imaging technique for evaluation of
the upper and lower abdomen because it is almost universally available, is
noninvasive, lacks ionizing radiation, and is well accepted by patients.
Sonography of the urinary bladder is a quick method. If ultrasonography is
implemented as a triage for bladder infiltration in patients with cervical
carcinoma, and only those with a sonar finding suspicious of infiltration are
referred for cystoscopy, it would result in a decrease of 60% in the number of
cystoscopies without any decrease in diagnostic accuracy [5].
A cost analysis has indicated that this triage is more economical. Giampero et al
[4] prospectively assessed the diagnostic capabilities of transabdominal
sonography for showing focal bladder wall abnormalities.
??
Transvaginal ultrasonography has been found to be superior to transabdominal
ultrasonography in the visualisation of pelvic pathology [20]. The posterior
bladder wall can be easily be inspected by the transvaginal route in the absence
of gross vaginal pathology. However, the value of transvaginal ultrasound to
detect posterior bladder wall infiltration has not been conclusively investigated
yet. In large exophytic cervical tumours, which bleed easily on contact, the
transvaginal approach will be impossible.
Endosonography offers two major advantages in the pre-therapeutic
examinations of a histologically verified carcinoma of the uterus.
Endosonography allows  an overview of the size and location of the tumour and
an evaluation of the spreading and involvement of adjacent organs. Both add up
to a more objective staging of the tumour and, therefore, may cause a more
effective therapeutic approach. Especially in cases with endometrial carcinoma,
the uterine walls can be visualized either by the well-tolerated method of
vaginosonography or by hysterosonography which can be performed only in
general anaesthesia.
Applying either endosonographical method, the infiltration depth of the
myometrium and involvement of the cervix  can be determined, which seems to
be very valuable, particularly when differentiating between stages I and II.
Rectosonography, with its transversal scanning probes, offers the advantage of
??
demonstrating the infiltration of a cervical  tumour into the parametrium. Here
again, the benefit is seen in a more objective evaluation of tumour size and
extension.
However, tumour growth into the urinary bladder is best shown by
cystosongraphy. With this method one cannot only have a view of the
epithelium (as in cystoscopy) but one is also able to evaluate the underlying
layers of the bladder wall. This seems to be an advantage in findings of a
bullous oedema. Once again, rectosonography is advantageous in enhancing the
diagnosis of recurrences of malignant tumours in the pelvic region. Like a
prolongation of the palpating finger rectosonography is able to depict less
echogenic areas located high up on the pelvic wall as local recurrences or
tumours.
 Iwomoto et al [21] evaluated the use of transvaginal ultrasonography for
diagnosing invasion of the bladder by cervical cancer. A transvaginal transducer
was inserted into the anterior fornix of the vagina and the bladder wall was
studied in the sagital plane. The movability of the bladder was assessed by the
ability of the bladder to slide along the uterine cervix when the probe was
pushed up against the bladder from the anterior fornix. Movability was
considered to indicate an intact bladder wall. All the patients underwent
computed tomography and cystoscopic examination also. Five had magnetic
??
resonance imaging. The accuracy was 95% for transvaginal ultrasonography,
76% for CT, 86% for cystoscopy and 80% for MRI. They concluded that
transvaginal ultrasonographic examination was useful for detecting invasion of
the bladder wall by cervical cancer.
Excretory urography is a sensitive test in the detection of urinary obstruction. In
the FIGO staging, excretory urography has been considered an integral part of
the initial evaluation because the presence of hydronephrosis or nonfunctioning
kidney resulting from ureteral obstruction advances the staging to 3B and is of
prognostic importance[22]. However, the yield of tumour related abnormalities
demonstrated by excretory urography in patients with gynaecological
malignancy is low [23,24].
Huang et al retrospectively analyzed correlation between transvaginal
ultrasound and bladder wall invasion in different stages of carcinoma of cervix.
Disruption of the endopelvic fascia, a thickened bladder wall, changes in the
bladder mucosa and interruption of the entire bladder wall were
ultrasonographic characteristic demonstrating the sequential stages of bladder
wall invasion in this study[4].
??
de Jonge et al studied the potential of transabdominal ultrasound to demonstrate
the presence or absence of bladder infiltration in patients with cervical
carcinoma and found that transabdominal ultrasound had a sensitivity of 100%,
a specificity of 76.5%, a positive predictive value of 60.4% and a negative
predictive value of 100% [6]. In another retrospective study by Sunderborg et
al, pelvic computed tomographic(CT) scan findings were correlated with
cystoscopic findings in patients with FIGO stage 2B or greater cervical cancer
and found that CT scan had a positive predictive value of 60% and negative
predictive value of 100% [6].
Computed tomography(CT) has been advocated as a screening tool in
evaluation of gynaecologic malignancies because it is noninvasive and may
detect disease not found by usual staging methods[25,26,27]. In patients with
cervical cancer, CT often is used to determine parametrial involvement,
adenopathy, adjacent organ invasion and to help design radiation therapy. CT
has staging accuracy ranging from 32% to 80% in cervical cancer. The
sensitivity for parametrial invasion ranges from 17% to 100% with an average
of 64%. Specificity ranges from 50% to 100% with an average of 81%. There is
a consensus in the literature that the value of CT increases with higher stages of
disease, and that CT has limited value (a positive predictive value of 58%) in
evaluating early parametrial invasion. However, CT has an accuracy of 92% in
??
depicting advanced disease. The major limitation of CT in local staging is its
inadequate differentiation between tumor and normal cervical stroma or
parametrial structures. Therefore, CT is mainly used in advanced disease and in
the assessment of lymph nodes. The positive predictive value of CT for nodal
involvement is 65% with a negative predictive value of 86%. CT is also
performed to detect distant metastases, for radiotherapy planning, and for
guiding interventional procedures.
Sundborg et al [6] did a retrospective analysis to determine the utility of
cystoscopy to rule out bladder invasion in cervical cancer patients who had
pelvic CT scan. The positive predictive value of CT scan in predicting bladder
invasion was 60 %. The negative predictive value of CT scan in predicting
bladder invasion was 100%.
The CT scan criteria for bladder involvement include the focal loss of
perivesical fat plane accompanied by asymmetrical wall thickening, nodular
indentations along the bladder wall, intraluminal tumour mass and a
vesicovaginal fistula [28,29].
??
Magnetic resonance imaging (MRI) is very accurate in determining tumour size
and location, the depth of stromal invasion and the local extension of the
tumour. The staging accuracy of MRI ranges from 75% to 96%. In assessing
local tumour invasion, T2- weighted images are superior to contrast – enhanced
T1- weighted images. Although cross sectional imaging is expensive, it results
in net cost savings because it replaces a number of less-expensive procedures
[30].
However, in an era of increased cost consciousness, it may be appropriate to
estimate the efficacy of each test defined as the probability that it will detect
abnormalities suspicious for cancer.
3.3.2 Role of cystoscopy
Invasive cervical cancer may spread to the lower urinary tract by direct
invasion. Examination of the ureters and bladder is very important in evaluating
the extent of spread. The two methods most commonly used in the evaluation of
the urinary tract in cervical cancer patients are excretory urography and
cystoscopy. Cystoscopy is being used to establish the diagnosis of bladder
invasion. However it is an invasive investigation and may cause several acute
urinary symptoms.
??
Not all patients with cervical cancer need cystoscopy to rule out bladder
involvement. Sundborg et al [6] reviewed 49 patients with stage 2B or greater
cervical cancer who underwent both cystoscopy and CT scan before treatment.
Three patients with bladder invasion were identified by cystoscopy and all were
also identified with possible bladder invasion by CT scan. There were two cases
of possible invasion seen on CT scan, but subsequent cystoscopy proved no
invasion. They concluded that the utility of performing cystoscopy to rule out
bladder invasion in a patient with no evidence of bladder involvement on CT
scan was limited and might not be necessary.
In another study Liang et al [7] assessed the usefulness of cystoscopy in the
staging of cervical tumour. Both rigid cystoscopy and CT were performed
before treatment in patients with cervical cancer of FIGO stage IB or greater.
Cystoscopically directed biopsy specimens were taken from all areas in the
bladder which were suspected of cancerous development. If a jet of urine
spurting from each ureteral orifice was not found, a ureteric catheter was
inserted into the orifice to rule out ureteral obstruction. The cystoscopic
findings were compared with CT examination. A total of 100 patients were
included in that study. There were 30 stage IB cancers, 20 stage IIA, 17 stage
IIB, 5 stage IIIA, 18 stage IIIB, and 10 stage IV. A total of 90 patients had
squamous cell carcinomas and 10 had adenocarcinomas. Cystoscopy identified
??
eight patients with bladder invasion including one stage IIIA, two stage IIIB,
and five stage IV. All of these patients had CT indication of possible invasion.
CT indication of possible invasion was proved to be false by cystoscopy in two
patients. Both the sensitivity and the negative predictive value of CT for bladder
invasion were 100%. Of the 14 patients in whom ureteral obstruction was
diagnosed by ureteric catheterization, 11 cases were indicated by CT scan, but
for the other 3 patients CT found no significant ureteral obstruction. They
concluded that cystoscopy is indicated only in cervical cancer patients for
whom CT examination indicates possible bladder invasion.
Therattil DD et al [31] assessed the effectiveness of cysto-urethroscopy for the
staging of cervical cancer was evaluated in a review of 412 cases of advanced
squamous cell carcinoma. Only 10 of the 378 stage-3 cases and 19 of the 24
stage-4 cases had histopathologically confirmed vesical mucosal involvement.
All women underwent radiotherapy, regardless of the cystoscopic finding.
Overall, this study suggests that cysto-urethroscopy is an unnecessary, cost-
ineffective, invasive procedure that facilitates neither diagnosis nor treatment
planning. Transvaginal sonography may be a preferable technique for
evaluating vesical invasion, with use of cystoscopy reserved for endoscopic
decompression of the obstructed ureter.
??
MATERIALS AND METHODS
This study was performed in the department of urology, Christian
Medical college, Vellore, to assess the usefulness of cystoscopy in comparison
to transabdominal ultrasonogram in staging of carcinoma cervix, on 92 adult
patients with newly diagnosed carcinoma of cervix with FIGO stage 2B and
higher stages. Emphasis was given to any sonographic evidence for bladder
involvement. All of them underwent bladder ultrasonography before performing
cystoscopy. Transabdominal ultrasound was done and reported in a unified
format with particular emphasis for urinary bladder involvement and
hydronephrosis. The technique required a full bladder in order to visualize the
posterior bladder wall, which then examined by transverse and coronal sections.
A normal posterior bladder wall shows up as a smooth echo-dense lining about
3 mm thick. Bladder infiltration is seen as a nodular irregularity.
Study design:
            Descriptive
Setting:
Outpatient procedure room of the urology department
Period of recruitment
 1st May   2009 to 31st Jan 2010.
??
Study population:
 Ninety two consecutive patients with histologically proven carcinoma of
the cervix.
Inclusion Criteria
Patients evaluated in Radiotherapy/Gynaecology OPD and diagnosed to
have carcinoma of cervix, FIGO stage 2B and above,  were included in
this study.
Exclusion Criteria
Ca cervix with FIGO stage lesser than 2B and post radiotherapy patients
(recurrent disease and partly treated patients)
Data collection
Personal interviewing of the patient, PACS (Picture Archiving and
Communication System) for transabdominal ultrasonogram findings,
personal observation of the cystoscopic findings and pathology reports
of the bladder biopsy whenever required.
Main outcome measurements:
The findings on transabdominal ultrasonogram and Cystoscopy which
were designated as normal, suspicious or infiltration.
??
Parameters observed:
o Age
o Symptoms
? Haematuria, Discharge PV, Bleeding PV, Bowel symptoms
o Examination findings
? Performance status
? Abdomen
? PV : Parametrium , DRE : Rectal mucosa
o Ultrasonogram findings
o Cystoscopy findings
? Urethra, Trigone, Bilateral ureteric orifices, posterior wall,  any
suspicious areas
o Biopsy:
? Number, Histopathology report
o During cystoscopy any suspicious area in the bladder mucosa which is
likely to be involved by the tumour was biopsied.  Cystoscopy was done
using a rigid cystoscope with field of view of 30° (Karl Storz, Germany)
under local anaesthesia. The number, location, and size of the tumours
were individually determined, reported on a separate sheet, and then
entered into the database after cystoscopy for later comparison with the
??
sonographic findings. Histologic specimens were fixed in 10% formalin
and sent to the pathology department.
Bias: Nil
Sample size:
With a positive predictive value of 60% (as per the previous studies),
confidence interval of 95% and precision of 10 % the sample size
required in the study group was 92.
Statistical analysis:
SSPS package 16.0 was used to compute the statistical analysis. The
cystoscopic findings were compared with sonographic findings and
relative values for sensitivity, specificity, positive predictive value,
negative predictive value and overall accuracy were calculated. Chi
square test were used for quantitative and qualitative type of data.
Sensitivity = True positive cases (TP) / True positive cases + False
Negative cases (FN)
Specificity = True negative (TN) / False positive(FP) + True negative
Positive predictive value = TP / TP + FP
Negative predictive value = TN / FN + TN
Overall accuracy = TP + TN / Total number of cases
??
Ethical Consideration
The institutional Review Board (IRB) considered the study in its ethics
committee and cleared the same before the study was started.
??
RESULTS
Ninetytwo patients were enrolled into the study as per the inclusion criteria.
Those with recurrent disease and partly treated with radiotherapy were excluded
from the study. All underwent ultrasonogram examination of the abdomen and
pelvis before cystoscopy.
5.1 Age
Age No %
30-39 12 13.0
40-49 34 36.9
50-59 28 30.4
60-69 13 14.1
70-79 4 4.3
80-89 1 1.1
Total 92 100
Table 1: Age distribution of the patients
Majority of the patients belonged to fifth and sixth decade. Mean age at
presentation was 50.06 with a standard deviation of 10.59.
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Fig. 2: Bar diagram showing age distribution of the patients
5.2 Symptoms
Symptoms Number of patients Percentage
Bleeding PV 79 85.7
Discharge PV 53 57.6
Abdominal pain 32 34.8
Haematuria 3 3.3
Table 2: Clinical presentation of carcinoma cervix patients before evaluation.
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Fig 3. Bar diagram showing the clinical symptoms. X axis showing the different
symptoms and Y axis showing the percentage.
Pervaginal bleeding was the main presenting symptom, followed by discharge
per vaginum and abdominal pain. Three  patients had gross haematuria at the
time of presentation.
5.3 Stage of the disease at presentation
All patients were staged based on the clinical findings before subjecting for
ultrasonogram and cystoscopy. The distribution of patients according to the
stage were as follows.
??
0
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Stage 2B
Stage 3A
Stage 3B
Stage 4A
Stage Number Percentage Cumulative
percentage
Stage 2B 35 38.0 38.0
Stage 3A 03 03.3 41.3
Stage 3B 48 52.2 93.5
Stage 4A 06 06.5 100
Total 92 100
Table 3:  Stage of presentation with percentage of each stage.
Most of the patients belonged to stage 2B and 3B. Thirty eight percentage of
patients belonged to stage 2B and 52% belonged to stage 3B.
Fig. 4: Clinical stage of presentation with percentage of each stage.
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5.4 Bladder Ultrasonogram findings according to the stage.
Thirtyfour patients in stage 2B had normal bladder ultrasonogram finding.
There was no bladder infiltration in this stage. All three in stage 3A had normal
bladder  ultrasonogram finding. Fortyfour in stage 3B had normal bladder
whereas four in this stage had suspicious infiltration and one had definite
infiltration on bladder ultrasonogram. Of the six in stage 4A four had bladder
infiltration and two had normal bladder.
Normal
bladder
Suspicious
Infiltrations
Definite
Infiltration
Stage 2B 34 00 00
Staghe 3A 03 00 00
Stage 3B 44 04 01
Stage 4A 02 00 04
Total 83 04 05
Table 4: Ultrasonogram of bladder showing the bladder involvement in each
stage of carcinoma cervix
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Fig. 5: Ultrasonogram of bladder showing the bladder involvement in each
stage of carcinoma cervix
5.4.1 Hydronephrosis according to the stage
Hydronephrosis was present mainly in stage 3B and 4 patients. Only one patient
in stage 2B had hydronephrosis.
??
No hydronephrosis
Number ( % )
Unilateral
Hydronephrosis
Number (%)
Bilateral
Hydronephrosis
Number ( % )
Stage 2B 34 (97.1) 01 (2.9) 00
Staghe 3A 03 (100) 00 00
Stage 3B 36 (73.4) 09 (18.4) 04 (8.2)
Stage 4A 02 (33.3) 03 (50) 01 (16.7)
Total 75 (81.5) 13 (14.1) 05 (4.4)
Table 5. Hydronephrosis (unilateral and bilateral) in in each stage with percentage
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Fig. 6:  Hydronephrosis in in each stage
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5.5 Hydronephrosis and Cystoscopic findings correlation
Table 6: Comparison between ultrasonogram of Kidney and Cystoscopy
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Fig. 7: Comparison between ultrasonogram of Kidney and Cystoscopy
Normal cystoscopy
Number (%)
Bladder infiltration on
Cystoscopy: Number
(%)
No hydronephrosis 73 (83.9) 01(20)
Unilataeral
hydronephrosis
10 (11.5) 03 (60)
Bilateral hydronephrosis 04 (4.6) 01 (20)
??
There was no hydronephrosis on transabdominal ultrasonogram in 74 patients
(80.4%),  of which one had bladder infiltration on cystoscopy. Whereas, of the
18 with hydronephrosis, four had bladder infiltration. Of these, 13 had
unilateral hydronephrosis and five had bilateral hydronephrosis.  So, presence
of hydronephrosis was a predictor of bladder involvement in cervical
carcinoma.
5.6 Bladder ultrasonogram and Cystoscopy correlation
Normal
cystoscopy
Suspicious
changes on
cystoscopy
Bladder
infiltration on
cystoscopy
Total
Normal USG bladder 78 05 00 83
Suspicious bladder
infiltration on USG
02 00 00 02
Definite bladder
infiltration on USG
00 02 05 07
Total 80 07 05 92
Table 7. Cystoscopy findings compared to bladder ultrasonogram findings
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Fig. 8: Cystoscopy findings compared to bladder ultrasonogram findings
Of the 80 with normal cystoscopy findings 78 had normal bladder
ultrasonogram and two had suspicious infiltration. Of the seven with suspicious
infiltration of bladder on cystoscopy five had normal ultrasonogram and
evidence of infiltration. The biopsy report of bladder mucosa in this group was
negative for malignant infiltration of bladder. All five with bladder infiltration
on cystoscopy had bladder infiltration on ultrasonogram.
??
Positve Normal
Positive 05 (true positive) 04 (false
positive)
Normal 00 (false negative) 83 (true negative
P value: 0.0001
Table 8. 2x2 table showing the true positives, false positives, true negatives and
false negatives of bladder ultrasonogram findings compared to cystoscopy.
Five had features suggestive of bladder infiltration on ultrasonogram as well as
bladder infiltration on cystoscopy (true positive). Four had ultrasonogram
features suggestive of bladder infiltration but there was no bladder involvement
on cystoscopy (false positive). Eighty three patients had normal bladder
ultrasonogram as well as normal cystoscopy (true negative). None of the
???????
???????
??????
??????????
??
patients with normal ultrasonogram had bladder involvement on cystoscopy
(false negative).
That is, there were five true positive cases, four false positive cases, 83 true
negative and there were no false negative cases. So the sensitivity, specificity,
positive predictive value, negative predictive value and accuracy of the
ultrasonogram to detect the bladder mucosal involvement were calculated as
follows.
Sensitivity: 5 / 5+ 0  x 100 = 100%
Specificity: 83 / 83 + 4  x 100 = 95.4%
Positive predictive value: 5/ 5 + 4 x 100 = 55.55%
Negative predictive value: 83 / 83 + 0 x 100 = 100%
Overall accuracy : 83+ 5 / 92 x 100 = 95.6%
The prevalene of bladder infiltration was 5.4%.
??
5.7 Haematuia and Ulrasonogram
Normal cystoscopy  Bladder infiltration
With haematuria 00 03 (3.3%)
Without haematuria 89 (96.7%) 00
p value =0 .0001
Table 8. Cystoscopy findings in relation to haematuria at the time of
presentation
All the three patients who presented with gross haematuria  had bladder
infiltration on cystoscopy. This shows that haematuria can be taken a s a
predictor for bladder involvement in cervical carcinoma.
??
DISCUSSION
Accurate staging before instituting definitive therapy in carcinoma of the cervix
is very important. Cystoscopy is being conventionally done to rule out any
bladder involvement. However, studies which specifically investigated the role
of transabdominal ultrasonography in the diagnosis of bladder infiltration by
cervical carcinoma are very limited. The aim of this study was to assess the
usefulness of cystoscopy in staging of carcinoma cervix and to determine the
potential of transabdominal ultrasonography to demonstrate the presence or
absence of bladder infiltration in patients with cervical carcinoma.
There were 92 patients in this study which is comparable to sample size in
similar study [6]. Of the 92, 35 belonged to clinical stage 2B, three were stage
3A, 49 were stage 3B and six were stage 4A.  In a similar study by de Jonge et
al [6] the stage distribution was 39, 27 and 29 in stage 2, stage 3 and stage 4
respectively. In our study maximum number of patients were in stage 3 and the
number of patients in stage 4 were lesser compared to the other study.
In our study sensitivity, specificity, positive predictive value, negative
predictive value and accuracy of ultrasonogram in the detection of bladder
??
involvement were 100%, 95.4%, 55.5%, 100% and 95.6% respectively. In the
prospective study by de Jonge et al the corresponding values were 100%,
76.5%, 60.4%, 100% and 82.7% respectively. These findings were similar to
our study. In that study there was no false negative cases which was similar to
our result.  The high sensitivity and negative predictive value can be attributed
to the advancement in the imaging technology. With a negative predictive value
of 100%,  ultrasonogram can be strongly considered to rule out bladder
involvement in cervical carcinoma patients. As there was no false negative
cases, the issue of missing any lesion on ultrasonogram becomes negligible.
Deo SV et al [8] assessed the role of transabdominal pelvic ultrasound
(TAPUS) and computed tomography (CT) in the detection of bladder
involvement in advanced cancer of the cervix. TAPUS was performed in 65
patients and CT in 60 patients. Cystoscopy was performed in all patients and
the findings were taken as the gold standard for comparison of imaging data.
The sensitivity, specificity and accuracy of TAPUS were 65, 94 and 75%
respectively, while those for CT were 80,92 and 85% respectively. This was
comparable to the results of our study. They concluded that the accuracy of
TAPUS was comparable to the accuracy of other imaging modalities in the
detection of bladder involvement in cervical cancer and that it should be used
more frequently in developing countries that deal with a large number of
??
cervical cancer patients in view of its easy availability, low cost and absence of
exposure to radiation.
Giampiero et al [19] observed that the sensitivity, specificity, positive
predictive value, negative predictive value and overall accuracy of
transabdominal ultrasonogram to detect focal bladder wall abnormalities were
91.4%, 79.3, 91.4, 79.3 and 88.2% respectively. The sensitivity and negative
predictive values in our study was better than this study. The prevalence of
bladder infiltration in our study was 5.4%. In the prospective study by de Jongo
et al [5] the prevalence was 26.4%. There was significant decrease in bladder
infiltration of carcinoma cervix patients in our study.
If noninvasive modalities can be instituted for staging and which can replace
the conventional invasive methods, it will improve patient comfort as well as
delay in getting the test done. The issue is how accurate the tests are. One area
which require improvement in the case of transabdominal ultrasonogram to
detect bladder infiltration in cervical carcinoma is to minimize the false positive
cases. Having said that, at the same time it should not compromise sensitivity of
the imaging modality. This can be accomplished with improvement in
technology. Improved specificity is important to avoid inappropriate palliative
??
treatment in situations where radical treatment is indicated.  At the same time, a
more favourable positive predictive value could bring down the number of
patients who need cystoscopy to verify an ultrasonographic finding of
infiltration. This would add to the cost-effectiveness of bladder
ultrasonography.  As the prevalence of bladder infiltration was low in our
series, further studies with larger sample size may be helpful to arrive at better
conclusion.
??
CONCLUSION
In this study “Does Pretreatment Cystoscopy improve Staging in
Carcinoma Cervix?” it was found that the incidence of bladder infiltration due
to cervical carcinoma was 5.4%. Those who presented with haematuria had
bladder invasion on transabdominal ultrasonogram and confirmed by
cystoscopic bladder biopsy. Those with hydronephrosis had 15.8 times more
possibility of having bladder infiltration. The sensitivity, specificity, positive
predictive value, negative predictive value and accuracy of ultrasonogram in the
detection of bladder involvement were 66.7%, 94.38%. 28.57%, 98.8% and
93.55% respectively.
Transabdominal ultrasonogram is a useful triage method for the
evaluation of the bladder for infiltration by cervical carcinoma. It has an
excellent sensitivity and negative predictive value in detecting bladder
involvement. There was no false negative cases. Hydronephrosis and gross
haematuria were predictors of bladder involvement. All presented with
haematuria had bladder infiltration.  Based on the findings of our study, we
recommend the use of transabdominal ultrasonography of the bladder as a
screening test for bladder infiltration by cervical carcinoma. Cystoscopy may be
performed in those with abnormal findings on ultrasonography. This is more
??
cost-effective, non-invasive and less time consuming. This will avoid
cystoscopy in all patients with cervical carcinoma and cystoscopy can be
tailored to those with ultrasonogam findings suggestive of bladder carcinoma.
This approach is highly appropriate for countries with high incidence as well as
delayed presentation of cervical carcinoma.
??
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PROFORMA
Proforma for  study on “ Does Pretreatment Cystoscopy Improve Staging
in Carcinoma Cervix”
Name :                                      Age :
Hosp. Number :
Address :
Phone number :
Symptoms :
Haematuria
Bowel symptoms :
Abdominal Pain :
Bleeding PV :
Duration of Symptoms :
??
Co morbidities :  DM                HTN
Physical Examination :
Height :                    Weight :                                  BMI :
Performance status(ECOG) :
Abdomen : Flank tenderness:     Yes  /  No
 Mass :
Per Vaginal Examination :
Fornices :                   Right :                   Left :
Parametrium              Right :                    Left :
Rectal Examination : Rectal mucosa :
Investigations:
Urine microscopy :
Serum Creatinine :
Cervical Biopsy report :
Stage of the disease  :
USG findings :
??
Hydronephrosis                   Right :                  Left :
Bladder involvement :    No  infiltraion
Suspicious of infiltration
                                        Suggestive  of infiltration
Rectal involvement :
Cystoscopy findings :
Urethra :
Ureteric orifices:  Right :                            Left :
Trigone : Normal :
                Suspicious :
                Definitive lesion :
Other areas of bladder :
Bladder biopsy :
                        Number
                        Sites :
INFORMED CONSENT DOCUMENT
I,Mrs.-----------, aged --------years, daughter of---------------, resident of --
---------------  have consented to undergo cystoscopy as part of the treatment
for a diagnosed medical condition understanding that the findings will
benefit me in my treatment. I understand that photographs and/or video or
??
electronic recordings may occur or data collected during my procedure may
be used for internal performance improvement or educational purposes.
I hereby state that I am in no way coerced into participating in this
study and am participating of my own free will.
I have read this document or someone has explained the contents of this
document to me in a language I understand.
Signed :
Name :
Date :
Place :
Name and Signature of Doctor with Date
??
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?? ?????????? ??????? ?? ? ? ? 0 ? ? ? 2 ? ? ? ??????????????????????????
?? ????? ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ????????????????
?? ??????? ??????? ?? ? ? ? 0 ? ? ? ? ? ? ?
?? ??????????? ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ????????????????
?? ???????? ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ????????????????????
??
?? Karpagam ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ?????????????????
?? Lakshmi ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ????????????????
21 Nagapushanam 488601D 51 0 1 0 0 3 1 1 ? 1 ? 1
?? Chanchla ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ??
?? Thangammal ??????? ?? ? ? ? 0 ? ? ? ? ? ? ? ???????????
24 Gita Devi 513696D 52 0 0 0 0 1 1 1 ? 1 1 1 ????????????
25 Upneti Kumar 524336D 42 0 1 0 0 3 1 1
?
1 1 1
???????????????? ?
???????
26 Radhammal 503840D 40 1 1 0 0 4 3 1 ? 1 3 3
27 Srirangam 511132D 55 0 1 0 0 3 2 3 ? 1 1 1 ???
28 Chandra 499553D 38 0 1 0 ? 3 1 1 ? 1 2 2 ???????????
29 Nagarathinam 495354D 65 0 1 0 0 3 1 1 1 1 1 1 ????????
30 Amsa Mary 507772D 45 0 1 1 ? 3 1 1 ? 1 2 2
31 Subbulakshmi 502736D 48 0 0 0 ? 1 1 1 ? 1 1 1 ?????????????????
32 Kanniammal 086264B 40 0 1 0 ? 3 1 1 1 1 1 1 ?????????
33 Binapani 111778C 62 0 1 0 ? ? 1 1 1 1 1 1 ?????????????
34 Dhanam 537981D 53 0 1 0 ? 3 1 2 1 2 1 1 ??????????????
35 Geeta Devi 513696D 52 0 1 0 ? 1 1 1 1 1 1 1
36 Shanthi 055452B 38 0 0 0 ? 1 1 2 1 1 1 1 ??????
37 Malliga 529031D 55 0 0 0 ? 3 1 1 1 1 1 1 ???????????
38 Navaneetha 523621D 45 0 1 0 ? 3 1 1 1 1 1 1 ????????????????
??
39 Koteswary 468117D 50 0 1 0
?
3 1 1 1 1 1 1
??? ????????
????????????
40 Mita Mukherji 536005D 38 0 1 0 ? 1 1 1 1 1 1 1
41 Saritha Mishra 542485D 40 0 1 1 ? 1 1 1 1 1 1 1
42 Kamala 540952D 72 0 1 1 ? 1 1 1 1 1 1 1 ??????
43 Jamuna 521011D 50 0 1 1 ? 3 1 1 1 1 1 1 ???????
44 Malliga 489564D 51 0 1 0 ? ? 1 1 1 1 1 1 ????
45 Rajeswari 532777D 59 0 1 0 ? ? 1 1 1 1 1 1 ????
46 Kalaiselvi 508536D 42 0 0 0 ? 1 1 1 1 1 1 1 ??
47 Sadhana Saha 565057D 61 0 1 1 ? 1 1 1 1 1 1 1 ?????
48 Chinnammal 271247D 66 0 0 0 1 1 1 2 1 1 1 1
49 Saroja 552166D 65 0 0 0 ? 3 1 1 1 1 1 1
50 Kuppamma 802894B 40 0 0 0 1 3 1 1 1 1 1 1
51 Vijaya 560298D 43 0 1 1 1 4 1 2 1 1 1 1
52 Shanthi 558251D 38 0 0 0 1 1 1 1 1 1 1 1
53 Doli Mukherji 550577D 46 0 0 1 1 1 1 1 1 1 1 1
54 Umarani 557345D 48 0 1 0 1 1 1 1 1 1 1 1
55 Lalitha 545601D 37 0 1 0 1 3 ? 1 1 1 1 1
56 Anwara Begum 561521D 48 ? ? ? 1 3 ? 1 1 1 1 1
57 Meenakshi 557818D 55 ? ? ? 1 3 ? 1 1 1 1 1
58 Chandravathi 568052D 47 ? ? ? 1 1 ? 1 1 1 1 1
??
59 Devaki 567537D 38 ? ? ? 1 3 ? 1 1 1 1 1
60 Sundari 561420D 60 0 1 1 1 1 1 1 1 1 1 1
61 Santhamani 587673D 41 0 1 0 1 1 1 1 1 1 2 2
62 Sarojini 563643D 55 0 1 0 1 1 1 1 1 1 1 1
63 Parvathi Devi 562204D 55 0 1 0 1 1 1 1 1 1 1 1
64 Ratna Singh 432743D 44 ? ? ? 1 1 1 1 1 1 1 1
65
Kanchana
Kundu 574696D 67 0 1 1 1 3 1 2 1 1 1 1
66 Bithi Deb 580560D 62 0 1 0 1 3 1 1 1 1 1 1
67 Rehana 561698D 45 0 1 1 1 4 3 2 1 1 3 3
68 Subbamma 576491D 73 ? ? ? 1 3 3 2 1 1 3 ?
69 Vijiya 576326D 43 ? ? ? 1 3 1 1 1 1 1 1
70 Salima Bibi 584442D 52 ? ? ? ? 3 1 2 1 1 1 1
71 Margarate Mary 568467D 41 ? ? ? ? 3 1 1 1 1 1 1
72 Chitra 575277D 40 ? ? ? ? 1 1 1 1 1 1 1
73 Rekha Dutta 601239D 61 0 1 1 ? 3 1 2 1 1 1 1
74 Chandra 577451D 40 ? ? ? 1 ? ? 1 1 1 1 1
75 Bhagya 593345D 35 ? ? ? 1 ? ? 1 1 1 1 1
76 Saroja 590080D 50 ? ? ? 1 3 ? 2 1 1 1 1
77 Jayanti 592002D 52 ? ? ? ? ? ? 3 1 1 3 ?
78 Radhamani 518473C 45 ? ? ? 1 ? ? 1 1 1 2 2
??
79 Annammal 590263D 54 ? ? ? 1 ? ? 1 1 1 1 1
80 Putuli Soren 598122D 42 ? ? ? ? 1 ? 1 1 1 1 1
81 Thavamani 910048C 56 ? ? ? ? ? ? 2 1 1 3 3
82 Mita Burman 594616D 58 ? ? ? ? ? ? 1 1 1 1 1
83 Kasturi 601232D 39 ? ? ? ? ? ? 1 1 1 1 1
84 Chinnaponnu 598130D 55 ? ? ? ? ? ? 1 1 1 1 1
85 Sumitra Devi 302388C 73 ? ? ? ? ? ? 1 1 1 1 1
86 Kumari 599665D ?? ? ? ? ? ? ? 3 1 1 2 ?
87 Chitra 611666D 45 ? ? ? ? ? ? 1 1 1 1 1
88 ManjuSingh 610452D ?? ? ? ? ? 3 ? 2 1 3 1 1
89 Seetha 611006D 35 ? ? ? ? ? ? 1 ? 1 1 1
90 Jyotsna 617517D 55 ? ? ? ? ? ? 1 1 1 1 1
91 Maheswari 614204D 40 ? ? ? ? ? ? 2 1 1 1 1
92 Vasanthi 610938D 30 ? ? ? ? 3 ? 3 ? 1 2 2
??
